Safety, Tolerability, and Pharmacokinetics of a Long-Acting Broadly Neutralizing Human Immunodeficiency Virus Type 1 (HIV-1) Monoclonal Antibody VRC01LS in HIV-1-Exposed Newborn Infants.
Saved in:
| Title: | Safety, Tolerability, and Pharmacokinetics of a Long-Acting Broadly Neutralizing Human Immunodeficiency Virus Type 1 (HIV-1) Monoclonal Antibody VRC01LS in HIV-1-Exposed Newborn Infants. |
|---|---|
| Authors: | McFarland EJ; Department of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA., Cunningham CK; Department of Pediatrics, Duke University School of Medicine, Durham, North Carolina, USA., Muresan P; Statistical and Data Management Center/Frontier Science Foundation, Brookline, Massachusetts, USA., Capparelli EV; Departments of Pediatrics and Pharmacy, School of Medicine and Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, La Jolla, CA, USA., Perlowski C; FHI 360, Durham, North Carolina, USA., Morgan P; FHI 360, Durham, North Carolina, USA., Smith B; Division of AIDS, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, USA., Hazra R; Maternal and Pediatric Infectious Disease Branch, Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, Maryland, USA., Purdue L; Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health (Contractor), Bethesda, Maryland, USA., Harding PA; Department of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA., Theron G; Department of Pediatrics and Department of Obstetrics and Gynaecology, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa., Mujuru H; University of Zimbabwe College of Health Sciences-Clinical Trials Research Centre, Harare, Zimbabwe., Agwu A; Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Purswani M; Department of Pediatrics, BronxCare Health Systems, affiliated with Icahn School of Medicine at Mount Sinai, Bronx, New York, USA., Rathore MH; University of Florida Center for HIV/AIDS Research, Education and Service, University of Florida College of Medicine, Jacksonville, Florida, USA., Flach B; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., Taylor A; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., Lin BC; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., McDermott AB; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., Mascola JR; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., Graham BS; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA. |
| Corporate Authors: | International Maternal Pediatric Adolescent AIDS Clinical Trials Network (IMPAACT) P1112 Team |
| Source: | The Journal of infectious diseases [J Infect Dis] 2021 Dec 01; Vol. 224 (11), pp. 1916-1924. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural |
| Journal Info: | Publisher: Oxford University Press Country of Publication: United States NLM ID: 0413675 Publication Model: Print Cited Medium: Internet ISSN: 1537-6613 (Electronic) Linking ISSN: 00221899 NLM ISO Abbreviation: J Infect Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1537-6613 |
|---|---|
| DOI: | 10.1093/infdis/jiab229 |
